Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00606463 · ClinicalTrials.gov registry record · NA
Gen2 Isthmus-Dependent Atrial Flutter Ablation Study
A NA study, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00606463 is a NA study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 30 participants.
The verdict
NCT00606463, a NA study, was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Irrigated catheter for ablation of isthmus-dependent atrial flutter
Interventions
- DEVICE Cardiac Ablation (Gen2 Cardiac Ablation System)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00606463
The ClinicalTrials.gov registry entry for NCT00606463 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Ablation (Gen2 Cardiac Ablation System) is the first listed.
NCT00606463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00606463 about?
NCT00606463 is a clinical study titled "Gen2 Isthmus-Dependent Atrial Flutter Ablation Study". Irrigated catheter for ablation of isthmus-dependent atrial flutter
What is the current status of trial NCT00606463?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2008-02. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00606463?
The interventions under investigation include: Cardiac Ablation (Gen2 Cardiac Ablation System) (DEVICE).
Who is sponsoring clinical trial NCT00606463?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.